1,609
Views
13
CrossRef citations to date
0
Altmetric
Short Report

Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate

, , , , , , , , , , , & show all
Pages 3089-3096 | Received 14 Apr 2016, Accepted 06 Aug 2016, Published online: 28 Nov 2016

Figures & data

Figure 1. (A) J8-specific or (B) DT-specific serum IgG in SWISS mice (n = 5 female and n = 5 male mice) administered J8-DT/alum, DT/alum or PBS/alum with 2 or 3 intramuscular immunizations on days 0, 21 and 42 (x3 immunisations only). Mice were immunized as previously describedCitation30 with minor modifications. Briefly, 4–6 week old SWISS mice (n = 5 female and n = 5 male/group housed separately) were immunized intramuscularly on day 0 with J8-DT (50 ug), DT (50 ug) or PBS formulated with alum (Alhydrogel 2%). Selected cohorts were boosted on day 21 or on days 21 and 42. Sera from the cohorts were collected on selected days pre and post-immunisation. SWISS mice were purchased from The Animal Resource Centre, Western Australia. Statistical significance was calculated using GraphPad Prism version 6. One-way Analysis of Variance (ANOVA) was applied to evaluate significant differences in absorbance levels. The Dunnett's test was performed as a post-hoc test. A P value of < 0.05 was considered significant. Data was expressed as mean ± SEM.

Figure 1. (A) J8-specific or (B) DT-specific serum IgG in SWISS mice (n = 5 female and n = 5 male mice) administered J8-DT/alum, DT/alum or PBS/alum with 2 or 3 intramuscular immunizations on days 0, 21 and 42 (x3 immunisations only). Mice were immunized as previously describedCitation30 with minor modifications. Briefly, 4–6 week old SWISS mice (n = 5 female and n = 5 male/group housed separately) were immunized intramuscularly on day 0 with J8-DT (50 ug), DT (50 ug) or PBS formulated with alum (Alhydrogel 2%). Selected cohorts were boosted on day 21 or on days 21 and 42. Sera from the cohorts were collected on selected days pre and post-immunisation. SWISS mice were purchased from The Animal Resource Centre, Western Australia. Statistical significance was calculated using GraphPad Prism version 6. One-way Analysis of Variance (ANOVA) was applied to evaluate significant differences in absorbance levels. The Dunnett's test was performed as a post-hoc test. A P value of < 0.05 was considered significant. Data was expressed as mean ± SEM.

Figure 2. Immunogenicity and protective efficacy of J8-DT/alum in BALB/c mice. (A) Cohorts of BALB/c mice (4–6 weeks old) were subcutaneously immunised with 50 ug of J8-DT vaccine formulation on days 0, 21 and 28. The J8-specific IgG titers on days 20, 27 and 35 are shown. Efficacy of the vaccine formulation following bacterial skin challenge with 88/30 GAS strain for cohorts of mice that received either 1, 2 or 3 doses of vaccine and the control cohort administered PBS plus adjuvant. Skin (B and C) and blood (D and E) bioburden was determined for days 3 and 6 post-exposure respectively. Mean (+/− SEM) shown. A P value of <0.05 was considered significant. Statistical significance was calculated using GraphPad Prism version 6.

Figure 2. Immunogenicity and protective efficacy of J8-DT/alum in BALB/c mice. (A) Cohorts of BALB/c mice (4–6 weeks old) were subcutaneously immunised with 50 ug of J8-DT vaccine formulation on days 0, 21 and 28. The J8-specific IgG titers on days 20, 27 and 35 are shown. Efficacy of the vaccine formulation following bacterial skin challenge with 88/30 GAS strain for cohorts of mice that received either 1, 2 or 3 doses of vaccine and the control cohort administered PBS plus adjuvant. Skin (B and C) and blood (D and E) bioburden was determined for days 3 and 6 post-exposure respectively. Mean (+/− SEM) shown. A P value of <0.05 was considered significant. Statistical significance was calculated using GraphPad Prism version 6.

Table 1. In vitro opsonisation (mean %+/−SEM) of the GAS strain 88/30.

Figure 3. Immunogenicity of the vaccine formulation (J8-DT/alum) in New Zealand White rabbits. Rabbits were administered intramuscularly 50 ug of J8-DT/alum vaccine formulation on days 0, 21 and 42. J8-specific serum IgG titers were determined on the days indicated using a similar protocol used for the mice studies. New Zealand White Rabbits were sourced by Veterinary Institute, South Australia.

Figure 3. Immunogenicity of the vaccine formulation (J8-DT/alum) in New Zealand White rabbits. Rabbits were administered intramuscularly 50 ug of J8-DT/alum vaccine formulation on days 0, 21 and 42. J8-specific serum IgG titers were determined on the days indicated using a similar protocol used for the mice studies. New Zealand White Rabbits were sourced by Veterinary Institute, South Australia.

Figure 4. Antibody responses to rM5 and J8-peptide in immunized Lewis rats. IgG antibody reactivity of serum from Lewis rats immunized with rM5 (•), J8-DT (▪), DT (▴) or PBS (negative control) (▾), to rM5 (A) or J8-peptide (B). All rats received a primary immunization on day 0, followed by an intraperitoneal injection of B. pertussis on day 1 and 3. A booster was administered on day 7. Absorbance values of rat sera at 1:100 dilution are shown, with mean absorbance value presented as horizontal lines. Significance was determined by ANOVA with the post hoc Dunnet's test (*, P < 0.01; **, P < 0.001). Lewis rats were purchased from The Animal Resource Centre, Western Australia.

Figure 4. Antibody responses to rM5 and J8-peptide in immunized Lewis rats. IgG antibody reactivity of serum from Lewis rats immunized with rM5 (•), J8-DT (▪), DT (▴) or PBS (negative control) (▾), to rM5 (A) or J8-peptide (B). All rats received a primary immunization on day 0, followed by an intraperitoneal injection of B. pertussis on day 1 and 3. A booster was administered on day 7. Absorbance values of rat sera at 1:100 dilution are shown, with mean absorbance value presented as horizontal lines. Significance was determined by ANOVA with the post hoc Dunnet's test (*, P < 0.01; **, P < 0.001). Lewis rats were purchased from The Animal Resource Centre, Western Australia.

Figure 5. Histological features of myocardium (left panel) and heart valves (right panel) from Lewis rats. A representative histological section from rats immunized with PBS and adjuvant (negative control; A and B) had little or no infiltration of inflammatory cells into the myocardium or valvular tissue. Rats immunized with J8-DT (C and D) had minimal changes comparable to the negative control rats. However, in rM5-immunized rats (positive control; E and F) there was evidence of mononuclear cell infiltration (Arrows) in the myocardial and valvular tissue (H&E; original magnifications: A, C and E, x200; B, D and F, x400). The rat hearts were excised and fixed in 10% neutral buffered formalin for 48 h prior to being embedded in paraffin. Tissue samples were cut in 5 µm-thick sections on a microtome and stained with hematoxylin and eosin (H&E) using standard procedures. Sections were examined by a pathologist who was blinded to the treatment groups, using a light microscope fitted with a QImaging camera. Evidence of inflammatory changes and cellular infiltration in the myocardium and mitral, aortic and tricuspid valve leaflets were assessed.

Figure 5. Histological features of myocardium (left panel) and heart valves (right panel) from Lewis rats. A representative histological section from rats immunized with PBS and adjuvant (negative control; A and B) had little or no infiltration of inflammatory cells into the myocardium or valvular tissue. Rats immunized with J8-DT (C and D) had minimal changes comparable to the negative control rats. However, in rM5-immunized rats (positive control; E and F) there was evidence of mononuclear cell infiltration (Arrows) in the myocardial and valvular tissue (H&E; original magnifications: A, C and E, x200; B, D and F, x400). The rat hearts were excised and fixed in 10% neutral buffered formalin for 48 h prior to being embedded in paraffin. Tissue samples were cut in 5 µm-thick sections on a microtome and stained with hematoxylin and eosin (H&E) using standard procedures. Sections were examined by a pathologist who was blinded to the treatment groups, using a light microscope fitted with a QImaging camera. Evidence of inflammatory changes and cellular infiltration in the myocardium and mitral, aortic and tricuspid valve leaflets were assessed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.